Abstract
Nocardiosis is well-known opportunistic infection in immunocompromised patients. The timely diagnosis and treatment, however, is still a difficult problem. Recently, as newer molecular techniques, particularly 16S rRNA sequencing, are implemented, the diagnosis and management of the infection are improving. We report a case of lung abscess in a 39-year-old-man who underwent kidney transplantation. He was diagnosed of Nocardia elegans by 16S rRNA sequencing and was cured of the infection with appropriate antibiotic therapy.
References
1. Beaman BL, Burnside J, Edwards B, Causey W. Nocardial infections in the United States, 1972-1974. J Infect Dis. 1976. 134:286–289.
3. Wellinghausen N, Pietzcker T, Kern WV, Essig A, Marre R. Expanded spectrum of Nocardia species causing clinical nocardiosis detected by molecular methods. Int J Med Microbiol. 2002. 292:277–282.
4. Relman DA. Persing DH, Smith TF, Tenover FC, White TJ, editors. Universal bacterial 16S rRNA amplification and sequencing. Diagnostic molecular microbiology priniciples and applications. 1993. 1st ed. Washington DC: ASM Press;489–495.
5. Woo PC, Ng KH, Lau SK, Yip KT, Fung AM, Leung KW, Tam DM, Que TL, Yuen KY. Usefulness of the MicroSeq 500 16S ribosomal DNA-based bacterial identification system for identification of clinically significant bacterial isolates with ambiguous biochemical profiles. J Clin Microbiol. 2003. 41:1996–2001.
6. Nolte FS, Caliendo AM. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yoken RH, editors. Molecular detection and identification of microorgnisms. Manual of clinical microbiology. 2007. 9th ed. Washington DC: ASM Press;218.
7. National Committee for Clinical Laboratory Standards (NCCLS). Approved Standard. NCCLS document M24-A. Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes. 2003. Wayne, Pennsylvania, USA: NCCLS.
8. Peleg AY, Husain S, Qureshi ZA, Silveira FP, Sarumi M, Shutt KA, Kwak EJ, Paterson DL. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis. 2007. 44:1307–1314.
9. Yassin AF, Brenner S. Nocardia elegans sp. nov., a member of the Nocardia vaccinii clade isolated from sputum. Int J Syst Evol Microbiol. 2005. 55:1505–1509.
10. Goodfellow M, Orchard VA. Antibiotic sensitivity of some nocardioform bacteria and its value as a criterion for taxonomy. J Gen Microbiol. 1974. 83:375–387.
11. Watanabe K, Shinagawa M, Amishima M, Iida S, Yazawa K, Kageyama A, Ando A, Mikami Y. First clinical isolates of Nocardia carnea, Nocardia elegans, Nocardia paucivorans, Nocardia puris and Nocardia takedensis in Japan. Nippon Ishinkin Gakkai Zasshi. 2006. 47:85–89.
12. Agterof MJ, van der Bruggen T, Tersmette M, ter Borg EJ, van den Bosch JM, Biesma DH. Nocardiosis: a case series and a mini review of clinical and microbiological features. Neth J Med. 2007. 65:199–202.
13. Munoz J, Mirelis B, Aragon LM, Gutierrez N, Sanchez F, Espanol M, Esparcia O, Gurgui M, Domingo P, Coll P. Clinical and microbiological features of nocardiosis 1997-2003. J Med Microbiol. 2007. 56:545–550.
14. Simpson GL, Stinson EB, Egger MJ, Remington JS. Nocardial infections in the immunocompromised host: A detailed study in a defined population. Rev Infect Dis. 1981. 3:492–507.